These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29074775)

  • 1. A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress.
    Pino P; Caldelari R; Mukherjee B; Vahokoski J; Klages N; Maco B; Collins CR; Blackman MJ; Kursula I; Heussler V; Brochet M; Soldati-Favre D
    Science; 2017 Oct; 358(6362):522-528. PubMed ID: 29074775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmepsins IX and X are essential and druggable mediators of malaria parasite egress and invasion.
    Nasamu AS; Glushakova S; Russo I; Vaupel B; Oksman A; Kim AS; Fremont DH; Tolia N; Beck JR; Meyers MJ; Niles JC; Zimmerberg J; Goldberg DE
    Science; 2017 Oct; 358(6362):518-522. PubMed ID: 29074774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
    Qidwai T
    Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling and resistant alleles explain the selectivity of antimalarial compound 49c towards apicomplexan aspartyl proteases.
    Mukherjee B; Tessaro F; Vahokoski J; Kursula I; Marq JB; Scapozza L; Soldati-Favre D
    EMBO J; 2018 Apr; 37(7):. PubMed ID: 29519896
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
    Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax.
    Hodder AN; Christensen J; Scally S; Triglia T; Ngo A; Birkinshaw RW; Bailey B; Favuzza P; Dietrich MH; Tham WH; Czabotar PE; Lowes K; Guo Z; Murgolo N; Lera Ruiz M; McCauley JA; Sleebs BE; Olsen D; Cowman AF
    Structure; 2022 Jul; 30(7):947-961.e6. PubMed ID: 35460613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle.
    Favuzza P; de Lera Ruiz M; Thompson JK; Triglia T; Ngo A; Steel RWJ; Vavrek M; Christensen J; Healer J; Boyce C; Guo Z; Hu M; Khan T; Murgolo N; Zhao L; Penington JS; Reaksudsan K; Jarman K; Dietrich MH; Richardson L; Guo KY; Lopaticki S; Tham WH; Rottmann M; Papenfuss T; Robbins JA; Boddey JA; Sleebs BE; Sabroux HJ; McCauley JA; Olsen DB; Cowman AF
    Cell Host Microbe; 2020 Apr; 27(4):642-658.e12. PubMed ID: 32109369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages.
    Singh S; Rajendran V; He J; Singh AK; Achieng AO; Vandana ; Pant A; Nasamu AS; Pandit M; Singh J; Quadiri A; Gupta N; Poonam ; Ghosh PC; Singh BK; Narayanan L; Kempaiah P; Chandra R; Dunn BM; Pandey KC; Goldberg DE; Singh AP; Rathi B
    ACS Infect Dis; 2019 Feb; 5(2):184-198. PubMed ID: 30554511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents.
    Meyers MJ; Anderson EJ; McNitt SA; Krenning TM; Singh M; Xu J; Zeng W; Qin L; Xu W; Zhao S; Qin L; Eickhoff CS; Oliva J; Campbell MA; Arnett SD; Prinsen MJ; Griggs DW; Ruminski PG; Goldberg DE; Ding K; Liu X; Tu Z; Tortorella MD; Sverdrup FM; Chen X
    Bioorg Med Chem; 2015 Aug; 23(16):5144-50. PubMed ID: 25797165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmodium falciparum signal peptide peptidase is a promising drug target against blood stage malaria.
    Li X; Chen H; Bahamontes-Rosa N; Kun JF; Traore B; Crompton PD; Chishti AH
    Biochem Biophys Res Commun; 2009 Mar; 380(3):454-9. PubMed ID: 19174148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole-based non-peptidomimetic plasmepsin inhibitors.
    Kinena L; Leitis G; Kanepe-Lapsa I; Bobrovs R; Jaudzems K; Ozola V; Suna E; Jirgensons A
    Arch Pharm (Weinheim); 2018 Sep; 351(9):e1800151. PubMed ID: 30063266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds.
    Dans MG; Weiss GE; Wilson DW; Sleebs BE; Crabb BS; de Koning-Ward TF; Gilson PR
    Int J Parasitol; 2020 Mar; 50(3):235-252. PubMed ID: 32135179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.
    Mohapatra SC; Tiwari HK; Singla M; Rathi B; Sharma A; Mahiya K; Kumar M; Sinha S; Chauhan SS
    J Biol Inorg Chem; 2010 Mar; 15(3):373-85. PubMed ID: 19946719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria parasite plasmepsins: More than just plain old degradative pepsins.
    Nasamu AS; Polino AJ; Istvan ES; Goldberg DE
    J Biol Chem; 2020 Jun; 295(25):8425-8441. PubMed ID: 32366462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors.
    Kumar Singh A; Rajendran V; Singh S; Kumar P; Kumar Y; Singh A; Miller W; Potemkin V; Poonam ; Grishina M; Gupta N; Kempaiah P; Durvasula R; Singh BK; Dunn BM; Rathi B
    Bioorg Med Chem; 2018 Jul; 26(13):3837-3844. PubMed ID: 29983285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional profiling, identification, and inhibition of plasmepsins in intraerythrocytic malaria parasites.
    Liu K; Shi H; Xiao H; Chong AG; Bi X; Chang YT; Tan KS; Yada RY; Yao SQ
    Angew Chem Int Ed Engl; 2009; 48(44):8293-7. PubMed ID: 19784986
    [No Abstract]   [Full Text] [Related]  

  • 18. Bridging the Gap in Malaria Parasite Resistance, Current Interventions, and the Way Forward from in Silico Perspective: A Review.
    Kumi RO; Oti B; Abo-Dya NE; Alahmdi MI; Soliman MES
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36432016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation and substrate processing topography of the Plasmodium falciparum invasion/egress protease plasmepsin X.
    Mukherjee S; Nguyen S; Sharma E; Goldberg DE
    Nat Commun; 2022 Aug; 13(1):4537. PubMed ID: 35927261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
    Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
    PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.